Results 31 to 40 of about 18,801 (261)

How to use the fractional exhaled nitric oxide test [PDF]

Archives of disease in childhood - Education & practice edition, 2021
Measurement of fractional exhaled nitric oxide (FeNO) has become a mainstream, NICE-recommended, objective test of asthma severity. We explore the uses and practical issues with the FeNO test using clinically relevant questions for general paediatricians.
Rhiannon Hoggins, Madhavi Velpula, Susan Woodward, Mark Peter Tighe   +3 more
openaire   +2 more sources

Evaluation of fractional exhaled nitric oxide in school-age children with asthma and sensitization to cat allergens

Ukrainian Scientific Medical Youth Journal, 2022
bronchial asthma is a chronic condition that is considerably prevalent among children. According to scientific evidence, cat allergens are most frequently responsible for the onset of asthma manifestations in children. Children are more likely to develop
Mariia Kryvopustovа
doaj   +1 more source

Understanding the Cellular Sources of the Fractional Exhaled Nitric Oxide (FeNO) and Its Role as a Biomarker of Type 2 Inflammation in Asthma

BioMed Research International, 2022
Fractional exhaled nitric oxide (FeNO) has gained great clinical importance as a biomarker of type 2 inflammation in chronic airway diseases such as asthma.
J. Escamilla-Gil, M. Fernández‐Nieto, N. Acevedo   +2 more
semanticscholar   +1 more source

The Correlation Between Fractional Exhaled Nitric Oxide (FeNO), Blood Eosinophil Count, Immunoglobulin E Levels, and Spirometric Values in Patients With Asthma

Cureus, 2023
Background and objective: In patients with asthma, fractional exhaled nitric oxide (FeNO) is a biomarker for eosinophilic airway inflammation. However, the correlation with the blood eosinophil count, immunoglobulin E (IgE), and spirometric values is not
M. Al Ghobain, Abdullah S. Alsubaie, Walaa A Aljumah, Fahad M Alrumayh, Khalid Aldawsari, Asma M. Alqahtani, Sultan Alotaibi   +6 more
semanticscholar   +1 more source

Exploring the Interaction between Fractional Exhaled Nitric Oxide and Biologic Treatment in Severe Asthma: A Systematic Review

Antioxidants, 2023
Background: Fractional exhaled nitric oxide (FeNO) is a biomarker of airway inflammation associated with airway hyper-responsiveness and type-2 inflammation.
T. Pianigiani, Lorenzo Alderighi, Martina Meocci, M. Messina, B. Perea, Simona Luzzi, L. Bergantini, M. D'alessandro, R. M. Refini, E. Bargagli, P. Cameli   +10 more
semanticscholar   +1 more source

Domiciliary fractional exhaled nitric oxide and spirometry in monitoring asthma control and exacerbations.

Journal of Allergy and Clinical Immunology: In Practice, 2023
BACKGROUND Domiciliary measurements of airflow obstruction and inflammation may assist healthcare teams and patients in determining asthma control and facilitate self-management.
Ran Wang, O. Usmani, K. Chung, J. Sont, A. Simpson, M. Bonini, P. Honkoop, S. Fowler   +7 more
semanticscholar   +1 more source

The study of fractional exhaled nitric oxide in newly diagnosed cases of bronchial asthma and chronic obstructive pulmonary disease

Indian Journal of Allergy Asthma and Immunology, 2021
INTRODUCTION: Fractional exhaled nitric oxide (FENO) is a measurement of fractional nitric oxide (NO) concentration in exhaled breath. It is a quantitative, noninvasive, simple, and safe method to measure airway inflammation for the assessment of airways
V Lakshmi, Priti Meshram, Ujjwal Kumar, Vishwanath Pujari, Pinkutty Sagar   +4 more
doaj   +1 more source

Fractional exhaled nitric oxide in asthma: an update [PDF]

Respirology, 2009
ABSTRACTIn asthma, clinical symptoms and lung function are insensitive in reflecting the underlying airway inflammation, and monitoring of this process has only recently become available. Fractional exhaled nitric oxide (FeNO) is now recognized as a reliable surrogate marker of eosinophilic airway inflammation and offers the advantage of being ...
Alessandra, Sandrini, D Robin, Taylor, Paul S, Thomas, Deborah H, Yates   +3 more
openaire   +2 more sources

Use of Fractional Exhaled Nitric Oxide to Guide the Treatment of Asthma: An Official American Thoracic Society Clinical Practice Guideline

American Journal of Respiratory and Critical Care Medicine, 2021
Background: The fractional exhaled nitric oxide (FENO) test is a point-of-care test that is used in the assessment of asthma. Objective: To provide evidence-based clinical guidance on whether FENO testing is indicated to optimize asthma treatment in ...
S. Khatri, J. Iaccarino, Amisha V. Barochia, I. Soghier, P. Akuthota, A. Brady, R. Covar, J. Debley, Z. Diamant, A. Fitzpatrick, D. Kaminsky, N. Kenyon, S. Khurana, B. Lipworth, K. McCarthy, Michael Peters, L. Que, K. Ross, E. Schneider-Futschik, C. Sorkness, T. Hallstrand   +20 more
semanticscholar   +1 more source

Fractional exhaled Nitric Oxide (FeNO) level as a predictor of COVID-19 disease severity

Nitric oxide, 2022
Objective To assess the feasibility of Fractional exhaled Nitric Oxide (FeNO) as a simple, non-invasive, cost-effective and portable biomarker and decision support tool for risk stratification of COVID-19 patients.
Yotam Lior, Noga Yatzkan, Ido Brami, Y. Yogev, R. Riff, Idan Hekselman, Moran Fremder, Gabriella S. Freixo-Lima, M. Be'er, I. Amirav, M. Lavie   +10 more
semanticscholar   +1 more source